Trial results evaluating the impact of community health workers on adherence to therapy for Type 2 Diabetes and Hypertension were posted on ClinicalTrials.gov on 2025-12-22. The study, which enrolled 168 participants, reported a median reduction in Hemoglobin A1c of -0.35 percentage points in patients with diabetes.

Background

Type 2 Diabetes and Hypertension are prevalent non-communicable chronic diseases that often require consistent adherence to therapy for effective management. In rural settings, access to consistent care and support can be a challenge. This study aimed to investigate whether integrating community health workers into routine care could improve outcomes for patients managing these conditions.

Trial design

This completed study enrolled 168 participants from rural clinics in Chiapas, Mexico. The trial focused on patients with Hypertension and Diabetes Mellitus, Type 2. It evaluated the effectiveness of a community health worker program when integrated into existing routine care.

Key results

The study reported the following key measurements:

What this means

The results suggest that the integration of community health workers into routine care can lead to measurable improvements in key health indicators for patients with Type 2 Diabetes and Hypertension. The median reduction of -0.35 percentage points in Hemoglobin A1c indicates improved glycemic control for diabetic patients. Similarly, the median reductions of -4.7 mmHg in systolic blood pressure and -2.2 mmHg in diastolic blood pressure point to better blood pressure management for hypertensive patients. These findings highlight the potential role of community health worker programs in enhancing chronic disease management, particularly in underserved rural areas.

Source

The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for study NCT02549495, titled 'Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico', were posted on 2025-12-22 on clinicaltrials.gov.